Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gonzalo Calvo

Showing results (1-10 of 227) with videos related to

Pageof 23
Sort By:
Kidney International. Supplement|October 16, 2004
Albuminuria as a surrogate marker for drug development: a European Regulatory perspectiveGonzalo Calvo, Fernando de Andres-Trelles
The Canadian Journal of Cardiology|September 19, 2020
Going the Long Noncoding RNA Way Toward Cardiac Regeneration: Mapping Candidate Long Noncoding RNA Controllers of RegenerationDavid de Gonzalo-Calvo, Christian Bär
Medicina Clinica|February 9, 2006
[Methodological recommendations of the Regulatory Agencies]Ferran Torres, Gonzalo Calvo, Caridad Pontes
European Heart Journal|July 31, 2018
Circulating non-coding RNAs as biomarkers to predict and monitor the response to exercise: chances and hurdlesDavid de Gonzalo-Calvo, Thomas Thum
Current Drug Discovery Technologies|August 16, 2011
Clinical drug development in thromboembolic diseases: regulatory and methodological approachGonzalo Calvo-Rojas, Antonio Gómez-Outes
Revista Espanola De Enfermedades Digestivas|April 3, 2014
Biosimilar therapy for inflammatory bowel diseaseCristina Avendaño-Solá, Julià Panés, Gonzalo Calvo
Trends in Molecular Medicine|June 14, 2022
Methodological considerations for circulating long noncoding RNA quantificationDavid de Gonzalo-Calvo, Miron Sopić, Yvan Devaux, et al.
Epigenomics|January 15, 2019
Circulating miRNAs as mediators in cell-to-cell communicationChristian Bär, Thomas Thum, David de Gonzalo-Calvo
Gaceta Sanitaria|October 26, 2005
[Comment. The role of regulatory agencies in the evaluation of drug safety: speaking about of selective serotonin receptor inhibitors]Francisco J de Abajo, Dolores Montero, Gonzalo Calvo
Clinical Chemistry and Laboratory Medicine|May 15, 2024
Navigating the path of reproducibility in microRNA-based biomarker research with ring trialsMiron Sopić, Yvan Devaux, David de Gonzalo-Calvo
Pageof 23

Showing results (1-10 of 227) with videos related to

Sort By:
Pageof 23
Kidney International. Supplement|October 16, 2004
Albuminuria as a surrogate marker for drug development: a European Regulatory perspectiveGonzalo Calvo, Fernando de Andres-Trelles
The Canadian Journal of Cardiology|September 19, 2020
Going the Long Noncoding RNA Way Toward Cardiac Regeneration: Mapping Candidate Long Noncoding RNA Controllers of RegenerationDavid de Gonzalo-Calvo, Christian Bär
Medicina Clinica|February 9, 2006
[Methodological recommendations of the Regulatory Agencies]Ferran Torres, Gonzalo Calvo, Caridad Pontes
European Heart Journal|July 31, 2018
Circulating non-coding RNAs as biomarkers to predict and monitor the response to exercise: chances and hurdlesDavid de Gonzalo-Calvo, Thomas Thum
Current Drug Discovery Technologies|August 16, 2011
Clinical drug development in thromboembolic diseases: regulatory and methodological approachGonzalo Calvo-Rojas, Antonio Gómez-Outes
Revista Espanola De Enfermedades Digestivas|April 3, 2014
Biosimilar therapy for inflammatory bowel diseaseCristina Avendaño-Solá, Julià Panés, Gonzalo Calvo
Trends in Molecular Medicine|June 14, 2022
Methodological considerations for circulating long noncoding RNA quantificationDavid de Gonzalo-Calvo, Miron Sopić, Yvan Devaux, et al.
Epigenomics|January 15, 2019
Circulating miRNAs as mediators in cell-to-cell communicationChristian Bär, Thomas Thum, David de Gonzalo-Calvo
Gaceta Sanitaria|October 26, 2005
[Comment. The role of regulatory agencies in the evaluation of drug safety: speaking about of selective serotonin receptor inhibitors]Francisco J de Abajo, Dolores Montero, Gonzalo Calvo
Clinical Chemistry and Laboratory Medicine|May 15, 2024
Navigating the path of reproducibility in microRNA-based biomarker research with ring trialsMiron Sopić, Yvan Devaux, David de Gonzalo-Calvo
Pageof 23